| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |